APGE NASDAQ
Apogee Therapeutics, Inc.
1W: +0.1%
1M: +0.7%
3M: +60.4%
YTD: +78.2%
1Y: +256.8%
3Y: +478.9%
$135.07
Last traded 2026-09-02 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships1
As Filer
counterparties named
1
As Counterparty
mentioned by others
1
Rel. Types
2023-06-23
Earliest Filing
2025-03-11
Latest Filing
supplier: 1
Counterparties (Filed by APGE)
1 relationshipsCompanies named in APGE's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Samsung Biologics Co., Ltd. | — | supplier | Agreement for Samsung to manufacture and supply APG777 drug substance for clinical development and commercial sale. | 2025-03-11 | View |
Mentioned As Counterparty
1 mentionsOther companies that named APGE in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-03 | Termination of Agreement; Acquisition/Disposition; Delisting Notice; Change in Control; Officer/Dire | Acquisition | View |
| 2026-08-11 | Officer/Director Change; Shareholder Vote | View | |
| 2026-08-10 | Earnings Release; Exhibits | View | |
| 2026-06-22 | Material Agreement; Exhibits | Agreement | View |
| 2026-06-22 | Material Agreement; Shareholder Vote; Regulation FD; Other Events; Exhibits | Agreement | View |
| 2026-06-12 | Shareholder Vote | View | |
| 2026-05-27 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-05-27 | Regulation FD; Other Events; Exhibits | View | |
| 2026-04-24 | Officer/Director Change | View | |
| 2026-03-25 | Material Agreement; Exhibits | Agreement | View |
| 2026-03-23 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-02 | Financial Statements and Exhibits | View | |
| 2026-01-06 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-10 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-10-10 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-08-11 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-07 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-23 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2025-03-11 | Entry into Material Definitive Agreement | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR